Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

NCT06616584 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

378

Enrollment

NETWORK

Sponsor class

Conditions

Recurrent Lung Non-Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8

Interventions

PROCEDURE: Biospecimen Collection
BIOLOGICAL: Cemiplimab
PROCEDURE: Computed Tomography
DRUG: Dexamethasone
DRUG: Docetaxel
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Ramucirumab

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]
[object Object]